ModelEdge

Ligand Pharmaceuticals Inc
LGND
Filing Type8-K
Filing Date7/13/2026
Updated7/14/26, 8:36 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Reg. FD
EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Reg. FD
GRAPHICGraphic